Header Logo

Connection

KAREN H LU to United States Food and Drug Administration

Back to Details
This is a "connection" page, showing publications KAREN H LU has written about United States Food and Drug Administration.
KAREN H LU
Connection Strength
0.037
United States Food and Drug Administration
  1. U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis. Obstet Gynecol. 2019 04; 133(4):795-802.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.